February 13, 2026 11:05 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers | Bangladesh poll manifestos mirror India’s welfare schemes as BNP, Jamaat bet big on women, freebies | Drama ends: Pakistan makes U-turn on India boycott, to play T20 World Cup clash as per schedule | ‘Won’t allow any impediment in SIR’: Supreme Court pulls up Mamata govt over delay in sharing officers’ details | India-US trade deal: ‘Negotiations always two-way’, says Amul MD amid farmers’ concerns | Khamenei breaks 37-year-old ritual for first time amid escalating Iran-US tensions | India must push for energy independence amid global uncertainty: Vedanta chairman Anil Agarwal | Kanpur horror: Lamborghini driven by businessman’s son rams vehicles, injures six
Coronavirus Vaccine
Image Credit: Unsplash

UK kickstarts 'booster shot' trials with seven different Covid-19 vaccines: Report

| @indiablooms | May 20, 2021, at 07:03 am

London/IBNS: As fight against coronavirus is prolonged, mainly due to the more dangerous new variants of the contagion, the United Kingdom launched a nationwide study on Wednesday to find safety and efficacy of a third dose "booster" shot of Covid-19 vaccines in strengthening immunity against the deadly virus, according to a Reuters report.

The study will have 3,000 participants, who have already taken the two doses of coronavirus vaccine, and examine the effect of a third dose across seven different vaccines, the report said, adding that some of these vaccines are already in use while others are in the process of development.

The new study aims at exploring the possibility of a booster inoculation ahead of winter after initially targetting immunisation of the entire adult population with a two dose schedule by summer, the report informed.

The vaccines included in the trial are Pfizer, AstraZeneca and Moderna COVID-19 shots, which are already being administered in Britain, as well as vaccines from Johnson & Johnson, Novavax, Valneva and CureVac which the country will source in future, it said.

British health minister Matt Hancock said that the data accumulated in the trial will help shape the government to devise the plan for the booster programme later this year, the report added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.